Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?

被引：2
|
作者：
Drueeke, Tilman B. [1 ,2 ]
Floege, Juergen [3 ]
机构：
[1] Paris Sud Univ, Inserm U 1018, Ctr Rech Epidemiol & Sante Populat CESP, Paris lle de France Ouest Univ, Villejuif, France
[2] Paris Saclay Univ, Villejuif, France
[3] Rheinisch Westfalische Tech Hsch Aachen, Univ Hosp, Dept Nephrol & Clin Immunol, Aachen, Germany
来源：
KIDNEY INTERNATIONAL | 2021年 / 99卷 / 05期
关键词：
PTH;
D O I：
10.1016/j.kint.2021.01.019
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In chronic kidney disease, parathyroid hormone (PTH), like all proteins, can undergo post-translational modifications, including oxidation. This can lead to structural and functional changes of the hormone. It has been hypothesized that currently used PTH measurement methods do not adequately reflect PTH-related bone and cardiovascular abnormalities in chronic kidney disease owing to the presence of oxidized, biologically inactive PTH in the circulation. Ursem et al. now report a strong correlation between serum non-oxidized and total PTH, and comparable associations with histomorphometric and circulating bone turnover markers, pleading against this hypothesis.
引用
收藏
页码：1070 / 1072
页数：3
相关论文
共 50 条
  • [1] Parathyroid hormone and growth in chronic kidney disease
    Waller, Simon
    PEDIATRIC NEPHROLOGY, 2011, 26 (02) : 195 - 204
  • [2] Parathyroid hormone and growth in chronic kidney disease
    Simon Waller
    Pediatric Nephrology, 2011, 26 : 195 - 204
  • [3] Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications
    Kritmetapak, Kittrawee
    Pongchaiyakul, Chatlert
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2019, 2019
  • [4] Should clinical laboratories adapt to the reality of chronic kidney disease in the determination of parathyroid hormone?
    Gonzalez-Casaus, Maria Luisa
    Fernandez-Calle, Pilar
    Soto, Antonio Buno
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2021, 2 (03): : 342 - 351
  • [5] Variability in parathyroid hormone assays confounds clinical practice in chronic kidney disease patients
    Eddington, Helen
    Hudson, Julie E.
    Oliver, Robert L.
    Fraser, William D.
    Hutchison, Alastair J.
    Kalra, Philip A.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2014, 51 (02) : 228 - 236
  • [6] Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
    Urena-Torres, Pablo A.
    Vervloet, Marc
    Mazzaferro, Sandro
    Oury, Franck
    Brandenburg, Vincent
    Bover, Jordi
    Cavalier, Etienne
    Cohen-Solal, Martine
    Covic, Adrian
    Drueke, Tilman B.
    Hindie, Elif
    Evenepoel, Pieter
    Frazao, Joao
    Goldsmith, David
    Kazama, Junichiro James
    Cozzolino, Mario
    Massy, Ziad A.
    CLINICAL KIDNEY JOURNAL, 2019, 12 (02) : 269 - 280
  • [7] Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease
    Seiler-Mussler, Sarah
    Limbach, Anne S.
    Emrich, Insa E.
    Pickering, John W.
    Roth, Heinz J.
    Fliser, Danilo
    Heine, Gunnar H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (04): : 569 - 576
  • [8] Parathyroid hormone metabolism and signaling in health and chronic kidney disease
    Evenepoel, Pieter
    Bover, Jordi
    Torres, Pablo Urena
    KIDNEY INTERNATIONAL, 2016, 90 (06) : 1184 - 1190
  • [9] Parathyroid Hormone, Hyperparathyroidism and Chronic Kidney Disease in Primary Care
    Tomonaga, Yuki
    Szucs, Thomas D.
    Risch, Lorenz
    Ambuhl, Patrice M.
    SWISS MEDICAL WEEKLY, 2013, 143 : 16S - 16S
  • [10] Parathyroid hormone measurement in chronic kidney disease stage 5
    Adams, Heather
    Osypiw, Jacqui
    Barker, Lindsey
    Naik, Ramesh
    Vaux, Emma
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 261 - 261
12345